Your browser doesn't support javascript.
loading
Prevalence of CYP2C19 and ITGB3 polymorphisms among Bangladeshi patients who underwent percutaneous coronary intervention.
Islam, Md Rabiul; Nova, Tasnova Tasnim; Momenuzzaman, Nam; Rabbi, Sikder Nahidul Islam; Jahan, Ishrat; Binder, Thomas; Islam, Mohammad Safiqul; Hasnat, Abul; Nahar, Zabun.
Afiliação
  • Islam MR; Department of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh.
  • Nova TT; Department of Pharmacy, Faculty of Science and Engineering, East West University, Dhaka, Bangladesh.
  • Momenuzzaman N; Department of Clinical Pharmacy and Pharmacology, Faculty of Pharmacy, University of Dhaka, Dhaka, Bangladesh.
  • Rabbi SNI; Department of Cardiology, United Hospital, Dhaka, Bangladesh.
  • Jahan I; Pharmacogenetics Laboratory, Labaid Limited (Diagnostic), Dhaka, Bangladesh.
  • Binder T; Pharmacogenetics Laboratory, Labaid Limited (Diagnostic), Dhaka, Bangladesh.
  • Islam MS; HLA Laboratory of the Stefan-Morsch-Fondation (SMS), Birkenfeld, Germany.
  • Hasnat A; Department of Pharmacy, Noakhali Science and TechnologyUniversity, Noakhali, Bangladesh.
  • Nahar Z; Department of Pharmacy, Faculty of Science and Engineering, East West University, Dhaka, Bangladesh.
SAGE Open Med ; 9: 20503121211042209, 2021.
Article em En | MEDLINE | ID: mdl-34471538

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prevalence_studies / Risk_factors_studies Idioma: En Revista: SAGE Open Med Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prevalence_studies / Risk_factors_studies Idioma: En Revista: SAGE Open Med Ano de publicação: 2021 Tipo de documento: Article